Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Therapeutic Drug Carrier Systems
Impact-faktor: 2.9 5-jähriger Impact-Faktor: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Druckformat: 0743-4863
ISSN Online: 2162-660X

Volumes:
Volumen 37, 2020 Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i5.20
pages 465-492

Pharmacogenomics and Its Potential Impact on Drug and Formulation Development

Karin Regnstrom
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA
Diane J. Burgess
Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA

ABSTRAKT

Recent advances in genomic research have provided the basis for new insights into the importance of genetic and genomic markers during the different stages of drug development. A new field of research, pharmacogenomics, which studies the relationship between drug effects and the genome, has emerged. Structural pharmacogenomics maps the complete DNA sequences of whole genomes (genotypes) including individual variations, and functional pharmacogenomics assesses the expression levels of thousands of genes in one single experiment. Together, these two areas of pharmacogenomics have generated massive databases, which have become a challenge for the research field of informatics and have fostered a new branch of research, bioinformatics. If skillfully used, the databases generated by pharmacogenomics together with data mining on the Web promise to improve the drug development process in a variety of areas: identification of drug targets, evaluation of toxicity, classification of diseases, evaluation of formulations, assessment of drug response and treatment, post-marketing applications, and development of personalized medicines.


Articles with similar content:

The Molecular and Cellular Biology of Pancreatic Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.8, 1998, issue 3-4
Theodore P. McDade, Frank J. Vittimberga, Jr. , Richard A. Perugini, Mark P. Callery
The Impacts of miRNAs in Glioblastoma Progression
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 2
Rasime Kalkan, Emine İkbal Atli
Monitoring Brain Oxygenation in Head-Injury Patients
Critical Reviews™ in Biomedical Engineering, Vol.37, 2009, issue 1-2
Justin Paul Phillips
Molecular Networks in Drug Discovery
Critical Reviews™ in Biomedical Engineering, Vol.38, 2010, issue 2
John Kenneth Morrow, Longzhang Tian, Shuxing Zhang
Resistance Mechanisms and Their Regulation in Lung Cancer
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 3-4
Manfred Volm, Jurgen Mattern